• Bloomberg

    Beyond Meat Products Pulled From Tim Hortons Canada Restaurants

    (Bloomberg) -- Tim Hortons restaurants have stopped selling Beyond Meat products at its coffee and donut shops across two of Canada’s biggest provinces.The chain had been serving the Beyond Burger and a Beyond Meat breakfast sandwich made with the company’s imitation sausage products. After an initial launch starting in June at nearly 4,000 Canadian locations, the items were scaled back to the provinces of Ontario and British Columbia in September.“We introduced Beyond Meat as a limited time offer. We are always listening to our guests and testing new products that align to our core menu offerings. We may offer Beyond Meat again in the future,” Tim Hortons said in an e-mailed statement.The rollback marks a rare setback for the plant-based meat maker, which currently has partnerships with Carl’s Jr., Hardee’s and Dunkin’ Donuts in the U.S., and recently announced an expansion of its partnership with Subway in Canada to begin serving meatball subs nationwide.A Beyond Meat spokesperson confirmed this was a limited time offer and the companies may work together in the future. Restaurant Brands International Inc., the parent company of Tim Hortons, didn’t respond.Beyond Meat tumbled almost 4% in New York trading Tuesday after the stock was downgraded to neutral by JPMorgan. The shares extended declines after the close of regular trading on the Tim Hortons report. The stock has soared more than fourfold since it went public last year.To contact the reporters on this story: Sandrine Rastello in Montreal at srastello@bloomberg.net;Deena Shanker in New York at dshanker@bloomberg.netTo contact the editors responsible for this story: Sally Bakewell at sbakewell1@bloomberg.net, David ScanlanFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • 3 “Strong Buy” Stocks Under $5 That Are Ready to Run Higher
    TipRanks

    3 “Strong Buy” Stocks Under $5 That Are Ready to Run Higher

    Whatever the reason a stock is trading for under $5 a share, these stocks are conversation starters. Some will point out the low valuation of these companies presents opportunity for upside which will be hard to come by when investing in a large-cap. What’s more, you can load up on a much larger number of shares than you could with a stock trading in triple or even double digits.On the other hand, the naysayers argue these tickers are likely to have bad fundamentals and face too many obstacles and, therefore, are more of a speculative shot at lottery like returns than an investment.Either way, both are right, and both could be wrong, too. The trick, as with any investment, is to find the most compelling opportunities the market presents.We went on our own intrepid search for 3 stocks trading at a bargain price, specifically looking for ones which those in the know think are poised to take off over the next 12 months. We used TipRanks’ Stock Screener tool which revealed that in addition to the low valuation, all three currently have a “Strong Buy” consensus rating. Let’s dive in.Orbcomm Inc. (ORBC)Orbcomm operates in an industry that is expected to grow substantially in the new decade. Orbcomm provides machine-to-machine (M2M) solutions across the globe, with its Internet of Things (IoT) technology used to track and monitor large assets. The company’s main markets are in transportation, heavy equipment, and government services, amongst others. Orbcomm is the only commercial satellite network 100% dedicated to M2M.The stock experienced a crushing 2019, losing almost 50% over the year due to disappointing earnings reports and transportation industry headwinds; Economic data suggests that in November, more than 1,000 truck drivers lost their jobs. Further data from October indicates heavy truck order activity is down 51% from 2018 levels.Canaccord's Michael Walkley expects the soft industrial data to continue until mid-2020 and believes it will affect some of Orbcomm’s hardware sales. Nevertheless, the analyst thinks “the shares have limited downside risk at the current valuation.”The 5-star analyst expounded, “Despite our cautious view of macro trends for a portion of Orbcomm’s transportation business unit, we believe the shares have priced in soft near-term hardware sales trends. With Orbcomm’s shares trading roughly 4X our 2021 adjusted EBITDA estimate, we view the risk reward on the shares as very positive… We believe if management can execute, the shares should return to higher multiples.”What does it mean, then? It means that Walkley keeps his Buy rating on Orbcomm. To reflect the headwinds, though, the price target comes down a notch, from $10 to $9. The reduced figure still represents outstanding returns in the shape of 132% could be in store over the next twelve months. (To watch Walkley’s track record, click here)Overall, the Street is with Walkley. 2 additional Buy ratings given to the M2M solutions provider over the last three months add up to a Strong Buy consensus rating. The average price target comes in at $7.67 and implies potential upside of a hefty 98%. (See Orbcomm stock analysis on TipRanks)Plug Power (PLUG)From M2M technology, we move on to another very modern solution, hydrogen fuel cell technology, or renewable energy. Plug Power’s fuel cell systems are designed to replace conventional batteries in electric vehicles and industrial trucks.In sharp contrast to ORBC, PLUG had an outstanding 2019. Its share price added considerable muscle in the shape of 154% throughout the year. Investors were buoyed by strong forecasts, management purchasing company stock, and an ambitious five-year plan, projecting revenue of $1 billion and adjusted EBITDA of $200 million.More good news has extended the rally into 2020; Plug is up by over 23% year-to-date following the announcement that it was awarded a $172 million contract for hydrogen fuel cell deployments from a Fortune 100 customer.B.Riley FBR’s Christopher Van Horn argues PLUG’s “stock and the fuel cell technology seem to be at an inflection point.” The 4-star analyst thinks the contract demonstrates the company’s competitive position, and with an addressable market of $30 billion, believes there should be more opportunities for PLUG coming up.Van Horn said, “PLUG has an implied 35% five-year CAGR from our 2019 revenue estimate and an almost 90% four-year CAGR from our 2020 adjusted EBITDA estimate. We believe this growth could come from its existing customer base, including Wal-Mart, Amazon, and others, as well as new customers. We think this award at roughly $172 million over two years is another step in the right direction to achieve these goals.”Therefore, Van Horn reiterated his Buy call on PLUG along with a price target of $6. This indicates upside potential of 54% over the next 12 months. (To watch Van Horn’s track record, click here)Is the Street ready to plug into PLUG? Yes, it is. The 5 Buy ratings and solitary Hold given over the last three months make the consensus rating a Strong Buy. An average price target of $4.50 puts the upside potential at 15%. (See Plug Power stock analysis on TipRanks)Carrols Restaurant (TAST)From modern solutions, we move to the food industry, where we take a seat at Carrols Restaurant. The company operates the largest Burger King franchisee in the world.It often happens that a stock trading for under $5 used to have a much larger market-cap, but for whatever reason, has lost its luster, and is now much cheaper. For Carrols, last year was a combination of underwhelming earnings reports plus a bizarre software mix up which charged customers incorrectly for discount meals that cost the company $8.3 million. As a result, the stock took a beating in 2019, starting the year at $9.84 and ending it down 28% at $7.05.The company recently announced preliminary 4Q19 results which has further worried investors; In October, Carrols had anticipated 4%-plus SSS (same store sales) for Burger King in its upcoming report, but the new data indicates the SSS figure lands at only 2%. Since then, the share price has dropped further and is down by 32% since the start of the year.So, should you stay away from TAST? Not according to SunTrust Robinson’s Jake Bartlett. The 5-star analyst explained, “TAST attributed the SSS miss to decreased traffic as Burger King laps its '10 Nuggets for $1' promotion last year (through mid-Feb.), a 'Winter Whopperland' game promotion in December that drove app downloads, but not sales, a potential impact from Popeye's new chicken sandwich (TAST's Popeyes 4Q19 21.2%-plus), a potential impact from MCD's '2 for $5' promotion and weak breakfast sales (negative in 4Q19 as lapped the $0.89 pancake promotion). While disappointing, TAST appears encouraged by upcoming menu innovation at Burger King… The promotional environment should remain balanced and significant acquisitions for both Popeyes and Burger King stores are expected in '20.”Accordingly, then, Bartlett reiterated a Buy recommendation on Carrols and kept his $14 price target. The target implies upside potential of a whopping 192%. (To watch Bartlett’s track record, click here)Currently, there are few on the Street taking a bite out of Carrols, but those who are, like the (TAST)e. A Strong Buy consensus rating is formed of 3 Buys, and at $8.83, the average price target suggests potential upside of a handsome 84%. (See Carrols Restaurant stock analysis on TipRanks)

  • Apple earnings and sales surge to record, sending stock toward new highs
    MarketWatch

    Apple earnings and sales surge to record, sending stock toward new highs

    Apple Inc. shares ticked higher in aftermarket trading after the company posted record quarterly results for its holiday quarter Tuesday afternoon while easily topping expectations.

  • ‘He owed a lot of back taxes.’ My ex-husband forgot to sign paperwork to split a sizable investment account — then he died. Can his estate claim that money?
    MarketWatch

    ‘He owed a lot of back taxes.’ My ex-husband forgot to sign paperwork to split a sizable investment account — then he died. Can his estate claim that money?

    One of our investment accounts was ordered to be split $30,000/$60,000, as per our divorce agreement. The investment company says the account is now all mine. Your question has two parts: can his estate come after you for back taxes and can his estate claim the money in your investment account.

  • Typical Retirement Savings By Age Groups: Are Yours Bigger?
    Investor's Business Daily

    Typical Retirement Savings By Age Groups: Are Yours Bigger?

    Are your IRA and 401(k) balances as big as retirement savings by other people your age? Bigger? If yours are smaller, here are tips for saving more.

  • TheStreet.com

    Jim Cramer: 6 Stocks to Buy on Coronavirus Fears

    The selling was so intense in that period that it didn't matter if you were buying Verizon or Caterpillar or American Electric Power . There were so many people who left Wuhan, the epicenter, when they were still healthy and they are now coming down with the illness. It's pretty clear that the virus spreads from rapidly person to person, so rapidly that we are hearing lots of conspiracies about a bio lab in Wuhan that might have mistakenly discharged the coronavirus and it was not transmitted initially by animals to humans.

  • What to expect in Tesla's 4Q 2019 earnings results
    Yahoo Finance

    What to expect in Tesla's 4Q 2019 earnings results

    Tesla is poised to report quarterly results Wednesday after market close, giving investors a look under the hood at the company’s financial performance as its operations in China ramped well ahead of schedule and deliveries hit a fresh record.

  • The problem with AMD’s data-center business
    MarketWatch

    The problem with AMD’s data-center business

    If Advanced Micro Devices Inc. is indeed serious about being in the data-center business, the chip maker needs to start telling investors what is happening in that business.

  • Jeff Bezos throws a D.C. shindig and Amazon employees protest policy
    American City Business Journals

    Jeff Bezos throws a D.C. shindig and Amazon employees protest policy

    Is it redundant to say that Amazon.com Inc. (NASDAQ: AMZN) founder and CEO Jeff Bezos threw a "lavish party" at his recently finished $23 million Kalorama mansion Saturday? The affair, held inside one of the District's largest homes, the converted former Textile Museum, was bound to be "lavish," as multiple news outlets noted.

  • 3 Tech Stocks to Play the 5G Boom In 2020
    TipRanks

    3 Tech Stocks to Play the 5G Boom In 2020

    We’re at a new turn in cellular technology, and the next few years will be interesting – to say the least – for techies. 5G networks are rolling out, and in fact, are already here. T-Mobile has a nationwide network in place, and other major providers have introduced 5G in large urban centers. The new technology promises to bring faster data streaming and higher density signals, making cell systems clearer, quicker, and more reliable.It will also change the hardware, a fact that usually slips below most casual users’ radar. But device and chip makers are well aware of 5G’s impact on handsets and tablets. Older chips are not compatible with the new technology, and semiconductor and smartphone makers – who have had a rough time in recent years – see a positive turn ahead as they roll out upgraded products.From an investor’s perspective, the hardware makers’ coming 5G boom represents an opportunity. As equipment manufacturers and end users switch to the new devices, the hardware companies will see increased sales, higher profits, and a consequent rise in share prices. In fact, the gains have already begun.With that in mind, we opened up the TipRanks' Stock Screener tool and pulled up three names that are going to make waves in 5G. All are large- or mega-cap companies, heavily invested in cellular and smartphone tech. All are Buy-rated – but they show different patterns of strength and weakness. Let’s jump into the details, and find out what makes them so compelling.Skyworks Solutions (SWKS)First up is Skyworks, a semiconductor chip supplier to the wireless handset industry. The company is focusing on small-cell and MIMO technology, applicable to the new networks. Small-cell, especially, will be important, as the high-end 5G signals have shorter range than existing systems – and will require a much denser network of small-cell towers and transmitters.Skyworks is a major supplier of RF chips, with heavy investments in the broadband, mobile, and wireless infrastructure segments. About 10% of sales go to the Asian giants Samsung and Huawei, but by far its largest customer – making up some 47% of total sales – is Apple (see below). Skyworks provides parts for the latest iPhone models, particularly the power amplifier and diversity receive front-end modules.Apple is predicting higher iPhone sales in the coming year, as the company adapts to the maturing handset market and rolls out 5G capable units. Skyworks, providing parts to the giant, is well-positioned to make gains on those new products – and, as a component provider, with minimal marketing overhead.Writing for B. Riley FBR, 5-star analyst Craig Ellis sees four positive takeaways from Skyworks' latest earnings report: “First, execution was strong down the line with high-quality sales, margin, inventory management, and cash generation outperformance. Second, 5G design wins with Sky5 product are broadly occurring, lending confidence F2Q’s above-seasonal guidance can persist in C2H20... Third … gross margins bucked adverse segment mix to surpass our expectation.... Lastly, a robust 32% FCF margin augurs well for ongoing cash return…” Ellis set a $150 price target on SWKS, along with his Buy rating, suggesting a 22% upside potential. (To watch Ellis’ track record, click here)Rajvindra Gill, another 5-star analyst, reviewed SWKS for Needham and also came to a bullish conclusion: “SWKS' higher-margin broad markets products continue to ramp across Wi-Fi, 5G infrastructure, and automotive. Given increased RF complexity in 5G handsets, we expect a meaningful Y/Y increase in iPhone blended $ content in FY20 ($7-$8). We expect sales growth and GM expansion throughout CY20 on increased strength in mobile and broad markets, driven by a strong rollout in 5G handsets…” Gill’s Buy rating comes with a $145 price target, showing confidence in an 18% upside. (To watch Gill’s track record, click here)Overall, SWKS holds a Moderate Buy rating from the analyst consensus view, based on 15 Buys and 8 Holds. The stock’s $131.70 average price target indicates room for about 13% upside from the current share price of $117. (See Skyworks’ stock analysis at TipRanks)Telefonakiebolaget LM Ericsson (ERIC)Next on our list is a major name in telecommunications, the Swedish-based manufacturer Ericsson. The company has long been a big name in mobile network technology, developing the software and equipment necessary for business and consumer wireless networks. Ericsson also has interests in the cable TV, mobile platform, and power module segments. Among the company’s assets, spread across 180 countries, are more than 49,000 patents, with a heavy emphasis on wireless tech.Canaccord's top analyst Michael Walkley sees plenty of reason for optimism in ERIC shares. In his comments on the stock, written just after the earnings report, Walkley states, “We believe Ericsson has the potential to gain market share and grow faster than their market growth assumptions… we believe Ericsson has a solid foundation for continued margin expansion and remains on track to achieve its 2020 operating margin target of >10% and 12-14% by 2022. With the recent EU cybersecurity report not singling out China as a threat… we believe Ericsson has the potential for solid share of China 5G contracts beyond the ~10% LTE share. We believe management has successfully stabilized the business and made the necessary changes for the company to invest for the 5G cycle…”Walkley puts a Buy rating on ERIC shares, and backs it with an $11 price target, implying a 33% upside potential to the stock. (To watch Walkley’s track record, click here)Ericsson stock is priced at a bargain for a major tech name – just $8.96 per share. With an average price target of $11.20, shares are showing room for 36% growth potential. The Strong Buy consensus rating is unanimous based on 5 Buys. (See Ericsson’s stock analysis at TipRanks)Apple, Inc. (AAPL)Last on our list is Apple, the Silicon Valley mega-corporation that recently became the most valuable publicly traded company in the world, with a market cap of $1.35 trillion. Apple boasts an installed customer base – that is, device users who have bought hardware and set up accounts – well over 900 million strong around the world, and reported total revenue in 2018 exceeding $265 billion.Apple will report fiscal Q1 results today, but the results from October’s fiscal Q4 report showed that the company is successfully implementing its shift away from dependence on iPhone sales to drive profits. The Services and Wearables segments posted 185 and 54% growth respectively, so that even though iPhone sales were lower than expected total revenues still gained, reaching $64 billion. EPS, at $3.03, beat the estimates by 6.7%. Apple beat the estimates in each reported quarter of 2019 so far, and calendar Q4 is normally the company’s strongest of the year – so analysts expect the company to report good news on Tuesday.As for guidance, Apple is sanguine. The company’s new iPhone models will be 5G compatible, and management expects the new technology to drive an increase in sales, as established customers upgrade their devices. AAPL shares have been rising steadily in the past twelve months, after high volatility in 2018, and closed at near-record levels last Friday. The stock’s 90-day gain is an impressive 29%.Writing on AAPL from Wedbush, 5-star analyst Daniel Ives sees the company continuing to make gains. He says, “We believe the company is poised to handily beat Street expectations in light of a strong holiday season with pent up demand catalyzing iPhone 11 purchases across the board… With currently 925 million iPhones worldwide and roughly 350 million of these iPhones in the "window of an upgrade opportunity" we believe Cupertino has a unique opportunity to capture this super cycle opportunity which will include a host of new smartphone versions/ models for iPhone 12. To this point, there are at least 5 iPhone versions that will launch in 2020 with the main event the 5G launch in September…”Ives gives AAPL a Buy rating, and backs it with a powerful $400 price target, suggesting room for 25% share appreciation. (To watch Ives’ track record, click here)Apple’s recent sustained share price gains have pushed the stock well above the average price target, faster than Wall Street’s analysts have been able to react. As Ives’ review shows, there is likely plenty of room for continued growth here. AAPL’s Moderate Buy consensus rating is based on diverse views, including 18 Buys, 12 Holds, and 3 Sells. (See Apple stock analysis at TipRanks)

  • Ex-Best Buy exec linked to CEO probe denies affair with Corie Barry
    American City Business Journals

    Ex-Best Buy exec linked to CEO probe denies affair with Corie Barry

    A former executive at Best Buy Co. Inc. who was alleged to have been romantically involved with Best Buy CEO Corie Barry — a claim that triggered an investigation of the retailer's leader — has denied the allegations.

  • Benzinga

    Q4 Earnings Preview For AT&T

    AT&T (NYSE: T ) will be releasing its next round of earnings this Wednesday, January 29. For all of the relevant information, here is your guide for Wednesday's Q4 earnings announcement. Earnings and Revenue ...

  • Benzinga

    4 Reasons To Buy Aurora Cannabis Stock

    It's been a rough year for cannabis stocks and even though Aurora Cannabis (NYSE: ACB ) is one of the most notable companies in the sector, it had its fair share of struggles in 2019. Following that yearlong ...

  • Goldman Sachs: 3 Healthcare Stocks to Snap Up Now
    TipRanks

    Goldman Sachs: 3 Healthcare Stocks to Snap Up Now

    Stuck for fresh investing inspiration? You’re not alone. After the stock market’s record-breaking performance in 2019, plenty of uncertainty lingers on Wall Street as we go forward into 2020. The U.S. presidential election coupled with new fears related to the spread of the coronavirus, which pushed the S&P 500 down 1.6% yesterday, have driven concerns that 2020 will see its fair share of volatility.Against this backdrop, investment banking giant Goldman Sachs published a report containing valuable insights. Highlighting the healthcare services sector in particular, the firm notes that while it anticipates fourth quarter results will fall in line with expectations, the key area to watch is 2020 guidance.“We believe 2020 outlooks will matter more, and see some potential for these updates to be overshadowed by political developments – specifically, upcoming Democratic primaries, where investors seem braced for a win (or two) by Senator Sanders, a Democratic candidate who supports the elimination of private health insurance,” analyst Stephen Tanal explained.To this end, the analyst argues that any weakness in the firm’s Buy-rated managed care organizations (MCOs) will present investors with an attractive entry point.Bearing this in mind, we’ve pulled up three of Goldman’s recent stock picks, and run them through TipRanks’ Stock Comparison tool to confirm that Goldman is in the majority on Wall Street in recommending these equities. Based on the information provided by the platform, each of the names has also garnered substantial support from other analysts, enough to earn a “Strong Buy” consensus rating. Humana Inc. (HUM)Healthcare is at the core of everything for medical insurance company Humana, whose goal is to not only improve healthcare, but also make it more accessible. While the company is off to a rocky start in 2020, Goldman Sachs believes several positives are in store.Tanal points to the permanent repeal of the health insurance fee (HIF), which will go into effect in 2021, as standing to benefit HUM. According to the analyst, the repeal “will have a disproportionately positive impact on HUM’s earnings given its group-high exposure to Medicare Advantage.” He added, “We expect out-year estimates to rise post 4Q and in the coming n months, as it appears that most sell side analysts have undershot the likely benefit of the repeal of the HIF.”Even though Tanal acknowledges that the company could face headwinds related to higher reimbursement rates for dialysis patients on Medicare Advantage plans, he estimates that the repeal will cover the headwind by a double-digit multiple.Adding to the good news, Humana's fourth quarter results are expected to be favorable. “We are comfortable with 4Q, too. At our recent healthcare CEO conference, HUM’s CEO noted that investors should not be overly concerned by the potential impact of the most widespread flu season in years,” Tanal wrote.With the stock trading at a 9% discount to the S&P 500, it seals the deal for Tanal. Given all that HUM has going for it, the analyst not only kept the rating as a Buy, but also added the name to the firm’s Conviction List. In addition, the $425 price target implies that shares could climb 23% higher in the next twelve months. (To watch Tanal’s track record, click here)Turning now to the rest of the Street, analysts are generally on board with HUM. 14 Buy ratings and 4 Holds assigned in the last three months add up to a Strong Buy Street consensus. Based on the $392.56 average price target, the upside potential lands at 13%. (See Humana stock analysis on TipRanks)Cigna Corporation (CI) Another health insurance name, Cigna’s approach has integrated the physical, emotional, financial, social and environmental aspects of health and well-being. Even after a solid six-month performance in which 16% was ticked on to the share price, Tanal thinks that there’s still plenty of room for CI to grow.As 2019 marked the first full year since its acquisition of Express Scripts, the Goldman Sachs analyst is expecting the company to post strong fourth quarter numbers. According to his projections, 2020 adjusted EPS guidance could fall within the range of $18.05 to $18.55. This figure “should leave room for ‘beat and raise’ quarters, in part because guidance typically excludes future capital deployment and any favorable prior period development.”The analyst cites three possible catalysts that could propel shares higher in 2020. First and foremost, the ramp of synergies from Express Scripts could have a significant impact, with the year-over-year step-up previously expected to be $273 million, or 3% of the midpoint of current 2019 guidance. On top of this, he points out that its deleveraging could generate a $154 million step-down in interest expense year-over-year and the earn-back of stranded costs related to the Anthem transition in 2019 stand to add $100 million to earnings.Tanal added, “Between the specialty launch pipeline, the Prime deal, the HIF repeal, proposed incremental capital deployment post the announced divestiture of the Group Disability and Life business and bigger than expected buybacks in 1Q-3Q 2019, we see a clear path to 2021 targeted adjusted EPS of $20 to $21.”In line with his optimistic take on CI, the analyst maintained a Buy rating and $245 price target. Should the target be met, shares could be in for a 24% twelve-month gain.What do other analysts have to say? As it turns out, the rest of the Street generally sides with the bulls. A Strong Buy consensus rating breaks down into 10 Buys, 1 Hold and 1 Sell. In addition, the $232.75 average price target indicates 16% upside potential. (See Cigna stock analysis on TipRanks)HCA Healthcare Inc. (HCA) Focusing on a different segment of the healthcare space, HCA operates hundreds of hospitals and clinics located throughout the U.S. Thanks to its performance exiting the third quarter, the Goldman Sachs analyst has high hopes for the healthcare name.Despite the investor concern ahead of its fourth quarter earnings release due to the volatility of the fundamentals in the first three quarters of 2019, Tanal notes that his bullish thesis is very much intact. Out of all the hospital and dialysis stocks he covers, HCA lands among the top two names expected to deliver the most potential upside compared to the adjusted EBITDA consensus estimate. Same-facility adjusted upside could be the source of the beat.For HCA, management’s outlook for 2020 will be essential, in the analyst’s view. He thinks the full year 2020 guidance will come in at around $10,260 million to $10,540 million, versus the Street’s $10,354 million forecast.“Labor costs are likely to be a focus heading into 2020 given continued robust job growth and low unemployment levels. Further, we will also be interested in any updated commentary on not-for-profit M&A opportunities, as recent acquisitions such as North Carolina-based Mission Health have delivered strong performance vs. the company’s initial expectations,” Tanal wrote.It also doesn’t hurt that admissions could see an increase as a result of the current flu season. It should come as no surprise, then, that the Goldman Sachs analyst reiterated his bullish call and $165 price target. This target conveys his confidence in HCA’s ability to surge 17% in the coming twelve months.Looking at the consensus breakdown, it appears that other analysts are on the same page. With 12 Buys compared to a single Hold, the word on the Street is that HCA is a Strong Buy. At $161.45, the average price target brings the potential twelve-month gain to 14%. (See HCA Healthcare stock analysis on TipRanks)

  • MarketWatch

    Xilinx stock falls more than 10% after weak fourth-quarter guidance, layoffs

    Xilinx Inc. shares fell more than 10.9% in the extended session Tuesday after the company reported fourth-quarter guidance below consensus estimates but higher-than-expected third-quarter sales. The company reported fiscal third-quarter net income of $162 million, or 64 cents a share, compared with $239.2 million, or 93 cents a share, in the year-ago period. Adjusted for items such as acquisition costs and amortization, among other things, earnings were 68 cents a share versus 92 cents a share a year ago. Revenue fell to $723.5 million from $800.1 million in the year-ago period. Analysts surveyed by FactSet had estimated earnings of 60 cents a share on revenue of $731.3 million. For the fiscal fourth quarter, analysts model earnings of 81 cents on sales of $825.1 million. The company said it expects fiscal fourth-quarter revenue of $750 million to $780 million. Xilinx also said it expects to lay off 7% of its workers because of "revenue headwinds" and has slowed hiring to replace attrition. Xilinx stock has fallen 9.8% in the past year, with the S&P 500 index rising 22.7%.

  • Benzinga

    General Electric's Q4 Earnings Preview

    On Wednesday, January 29, General Electric (NYSE: GE ) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Earnings and Revenue ...

  • AbbVie Is Nearing Takeover Of Allergan — Is It Time To Add AbbVie Stock?
    Investor's Business Daily

    AbbVie Is Nearing Takeover Of Allergan — Is It Time To Add AbbVie Stock?

    AbbVie stock fell on its $63 billion plan to acquire Botox-maker Allergan, which helps the pharmaceutical company diversify as Humira patents expire. So, is ABBV stock a buy right now?

  • Blink and you miss it: The U.S. yield curve inverts again
    Reuters

    Blink and you miss it: The U.S. yield curve inverts again

    An inverted yield curve has historically been an indicator of looming recession as it tends to reflect worries over future growth among bond investors. “The state of the U.S. economy seems to be steady as she goes,” said Michael Lorizio, senior fixed income trader at Manulife Asset Management. Various portions of the Treasury yield curve inverted in 2019 for the first time in years, sparking concerns that a recession may be looming.

  • Why Dow Jones Pharma Giant Pfizer Is Close To Triggering A Sell Rule
    Investor's Business Daily

    Why Dow Jones Pharma Giant Pfizer Is Close To Triggering A Sell Rule

    Pfizer stock toppled Tuesday after the Dow Jones pharmaceutical company reported declining fourth-quarter revenue and adjusted earnings that also missed Wall Street's expectations.

  • How to keep your retirement accounts safe
    MarketWatch

    How to keep your retirement accounts safe

    The thought of losing your life savings to hackers can be terrifying — and it’s why two of Houston financial adviser Michelle Gessner’s clients didn’t want to consolidate their retirement assets, even if the move would be financially savvy. The couple had already been the target of identity theft in the past, then with their credit cards, and they were afraid that if they rolled all their money together, they’d be “sitting ducks” at risk of losing their entire nest egg. “The question is real and understandable,” Gessner said.

  • What to know for year two of the Trump tax plan
    Associated Press

    What to know for year two of the Trump tax plan

    The IRS began accepting and processing tax returns for individuals on Monday. Last year’s filing season was an adjustment for taxpayers and industry professionals alike as it was the first under a massive overhaul of federal tax law. The standard deduction doubled under the new tax law that took effect in 2018.

  • Liz Weston: Retirees' top money regrets
    Associated Press

    Liz Weston: Retirees' top money regrets

    In a previous column, I detailed retirees’ biggest lifestyle regrets, such as not traveling more before their health gave out and not communicating clearly with a partner about what they hoped retirement would be like. The big ones, of course, are starting to save too late and not saving enough, but there are other common regrets, according to certified financial planners from the Financial Planning Association and the Alliance of Comprehensive Planners. About 1 out of 3 Social Security recipients apply for benefits at the earliest age, which is 62.